Tokyo, Japan and Cambridge, UK, 31 October 2025 - Nxera Pharma ("the Company" or "Nxera"; TSE: 4565) provides an update on operational activities and reports its consolidated results for the third qua ...
NPK International Inc. (NYSE: NPKI) ("NPK" or the "Company") today announced results for the three and nine months ended September 30, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback